GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhangzhou Pientzehuang Pharmaceutical Co Ltd (SHSE:600436) » Definitions » 3-Year EBITDA Growth Rate

Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) 3-Year EBITDA Growth Rate : 18.80% (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zhangzhou Pientzehuang Pharmaceutical Co 3-Year EBITDA Growth Rate?

Zhangzhou Pientzehuang Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥1.96.

During the past 12 months, Zhangzhou Pientzehuang Pharmaceutical Co's average EBITDA Per Share Growth Rate was 16.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 18.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 21.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 23.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Zhangzhou Pientzehuang Pharmaceutical Co was 38.90% per year. The lowest was 6.50% per year. And the median was 21.45% per year.


Competitive Comparison of Zhangzhou Pientzehuang Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Zhangzhou Pientzehuang Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhangzhou Pientzehuang Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhangzhou Pientzehuang Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhangzhou Pientzehuang Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.



Zhangzhou Pientzehuang Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Zhangzhou Pientzehuang Pharmaceutical Co  (SHSE:600436) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Zhangzhou Pientzehuang Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhangzhou Pientzehuang Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Shangjie, Xiangcheng, Fujian, Zhangzhou, CHN, 363000
Zhangzhou Pientzehuang Pharmaceutical Co Ltd produces and sells Chinese medicines. The company's product categories include drugs and healthcare products, healthy foods, cosmetics, daily chemicals, and medical instruments. Some of its products include Xinshubao Tablet, Yindan Pinggan Capsule, Liuwei Dihuang Pills, and Chuangbei Qingfei Syrup.

Zhangzhou Pientzehuang Pharmaceutical Co (SHSE:600436) Headlines

No Headlines